A trial looking at MK-2870 for oesophageal, stomach or gastro oesophageal junction cancer

Overview

Cancer types:

Oesophageal cancer, Secondary cancers, Stomach cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is comparing a new drug called MK-2870 with standard chemotherapy for cancer that has spread into surrounding tissues or to another part of the body.

It is for people whose cancer is getting worse despite treatment and who have one of the following:

  • cancer of the food pipe (oesophagus)

  • stomach cancer

  • cancer where the food pipe meets the stomach (gastro oesophageal junction cancer)

Recruitment start: 7 June 2024

Recruitment end: 6 January 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Was Mansoor

Supported by

Merck Sharp & Dohme LLC

Last reviewed: 17 Apr 2026

CRUK internal database number: 19934

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.